ReferenceRRK5821

MERLIN

An adaptive single arm multi-centre phase Iia clinical trial investigating the safety and activity of the use of a single infusion of sorted Mesenchymal Stromal Cells to reduce liver inflammation in the treatment of patients with primary sclerosing cholangitis and autoimmune hepatitis

Research Summary

Research Overview
Sponsor University of Birmingham
Project Status Open
Proposed End Date 01/12/2020
Study Run through CRF? Yes
Target number of patients agreed to recruit 32
Recruitment so far 4